APA (7th ed.) Citation

Goldinger, S. M., & Klemke, C. (2016). Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma: A phase 2 clinical trial. JAMA dermatology, 152(7), . https://doi.org/10.1001/jamadermatol.2016.0401

Chicago Style (17th ed.) Citation

Goldinger, Simone M., and Claus-Detlev Klemke. "Efficacy and Safety of APO866 in Patients with Refractory or Relapsed Cutaneous T-cell Lymphoma: A Phase 2 Clinical Trial." JAMA Dermatology 152, no. 7 (2016). https://doi.org/10.1001/jamadermatol.2016.0401.

MLA (9th ed.) Citation

Goldinger, Simone M., and Claus-Detlev Klemke. "Efficacy and Safety of APO866 in Patients with Refractory or Relapsed Cutaneous T-cell Lymphoma: A Phase 2 Clinical Trial." JAMA Dermatology, vol. 152, no. 7, 2016, https://doi.org/10.1001/jamadermatol.2016.0401.